Mativ Q4 sales miss estimates

Overview

• Specialty materials firm's Q4 sales rose 1% yr/yr but missed analyst expectations

• Adjusted EPS for Q4 beat analyst expectations

• Adjusted EBITDA for Q4 beat analyst expectations

Outlook

• Company remains focused on improving leverage and balance sheet by generating cash flow

• Mativ navigating an environment of anemic market demand and dynamic trade policies

• Company did not provide specific financial guidance for 2026 in press release

Result Drivers

• OPERATIONAL EXECUTION - Mativ attributed its performance to disciplined commercial operations, prudent inventory management, and effective SG&A expense management

• FAM SEGMENT GROWTH - Filtration & Advanced Materials sales rose 5.6% due to higher volume/mix and favorable currency translation, partially offset by lower selling prices

• SAS SEGMENT DECLINE - Sustainable & Adhesive Solutions sales fell 1.7% due to lower volume/mix, despite favorable currency translation and higher selling prices

Key Details

Analyst Coverage

• The one available analyst rating on the shares is "strong buy"

• The average consensus recommendation for the commodity chemicals peer group is "buy."

• Wall Street's median 12-month price target for Mativ Holdings Inc is $18.25, about 28% above its February 17 closing price of $14.26

• The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release: ID:nBw8DH1Fna

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.